Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.

Clinical trial NCT06781333 · RECRUITING

Trial details

NCT number: NCT06781333
Sponsor: Bernard (Barry) Baumel
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease Agitation in Dementia

Start date: 2025-04-29
Primary completion: 2027-12-15
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.